The Agency for Healthcare Research and Quality is seeking scientific information submissions on imaging tests for the staging of colorectal cancer.

Soliciting the information is part of an effort to pinpoint best practices under a comparative effectiveness review of such tests. These tests could include use of a chest x-ray, computed tomography, multi-detector computed tomography, CT colonography, magnetic resonance imaging, transabdominal endoscopic, and transrectal ultrasound; various types of positron emission tomography, or positron emission tomography combined with magnetic resonance imaging, according to a request for information available here.

AHRQ is asking manufacturers of these imaging systems to submit information. This includes a list of all completed relevant studies along with supporting information and the ClinicalTrials.gov trial number if applicable. “Your contribution is very beneficial to this program,” the agency notes. “The contents of all submissions will be available to the public upon request. Materials submitted must be publicly available or materials that can be made public.”

The RFI also seeks answers to a broad series of questions centering on test performances and outcomes.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access